These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14619483)

  • 1. [Relationship between effectiveness of hepatic artery injection chemotherapy and serum VEGF].
    Okada N; Ishida H; Takeuchi I; Yokoyama M; Nakata H; Hashimoto D; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1639-42. PubMed ID: 14619483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].
    Takeuchi I; Ishida H; Hashimoto D; Mastumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1686-8. PubMed ID: 14619494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic arterial injection of degradable starch microspheres (DSM) combined with adriamycin (ADM) and mitomycin C (MMC) in patients with liver metastasis of colorectal cancer].
    Takeuchi I; Ishida H; Inokuma S; Nakada H; Oosawa T; Sakimoto T; Hashimoto D; Kashimada A; Osada H
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1904-6. PubMed ID: 11086442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological examination of the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C for liver metastases of colorectal cancer--second report].
    Takeuchi I; Ishida H; Ohsawa T; Yokoyama M; Hoshino T; Hashimoto D; Osada H; Mastumoto Y; Miura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1800-2. PubMed ID: 15553720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
    Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of serial carcinoembryonic antigen (CEA): monitor to evaluate efficacy of continuous intrahepatic chemotherapy for nonresectable liver metastases of colorectal carcinomas].
    Yasuno M; Mori T; Takahashi K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1556-9. PubMed ID: 7574758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcatheter arterial chemoembolization to hepatic metastases from colorectal cancer].
    Maeda K; Hashimoto M; Katai H; Sakai S; Koh J; Yamamoto O; Hosoda Y; Suzuki K; Seki T; Horibe Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1542-5. PubMed ID: 8396907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
    Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined hepatic-artery and portal-vein chemoembolization for colorectal cancer metastatic to the liver].
    Tarazov PG; Granov DA; Polikarpov AA; Polisalov VN; Borovik VV
    Vopr Onkol; 2002; 48(1):83-7. PubMed ID: 12101575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of hepatic metastasis from colorectal cancer following arterial infusion chemotherapy--assessment from the percentage of tumor involved area and tumor markers].
    Suzuki S; Arai K; Arai H; Fukushima M; Murakami M; Ishii H; Itou Y; Kawamura M; Kusano M
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1437-9. PubMed ID: 8854773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin/mitomycin C].
    Takeuchi I; Ishida H; Ohsawa T; Nakada H; Inokuma S; Murata N; Hoshino T; Hashimoto D; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1760-2. PubMed ID: 11708028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B; Van Nieuwenhove Y; Aerts M; Fontaine C; Vermeij J; Schallier D; Decoster L; De Mey J; Vandenbroucke F; Hoorens A; Delvaux G; De Gréve J
    Anticancer Res; 2006; 26(1B):611-9. PubMed ID: 16739329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer].
    Itani K; Yoshikawa T; Oyamada H; Takano H; Ichikawa H; Tainaka K; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2897-900. PubMed ID: 2506828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer].
    Shimano T; Monden T; Morimoto H; Mori T
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):423-8. PubMed ID: 2321973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between anti-tumor effects and serum hepatocyte growth factor level in patients with liver metastases from gastric cancer treated by induced hypertensive chemotherapy with angiotensin II].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1874-7. PubMed ID: 9382555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of liver metastasis of gastric leiomyosarcoma successfully treated by transarterial hepatic chemo-embolization and intra hepato-arterial chemotherapy repeated with infusion-a-port].
    Miya A; Yasuda S; Morimoto O; Tsuji Y; Shiozaki K; Baba M; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1878-81. PubMed ID: 9382556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.